Heterogeneity of determining disease severity, clinical course and outcomes in systemic sclerosis-associated interstitial lung disease: a systematic literature review
L Petelytska, F Bonomi, C Cannistrà, E Fiorentini… - RMD open, 2023 - rmdopen.bmj.com
Objective The course of systemic sclerosis-associated interstitial lung disease (SSc-ILD) is
highly variable and different from continuously progressive idiopathic pulmonary fibrosis …
highly variable and different from continuously progressive idiopathic pulmonary fibrosis …
[HTML][HTML] Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: From Bedside to Bench and Back Again
M Bahi, C Li, G Wang, BD Korman - International Journal of Molecular …, 2024 - mdpi.com
Systemic sclerosis (SSc) is a heterogeneous disease characterized by autoimmunity,
vasculopathy, and fibrosis which affects the skin and internal organs. One key aspect of SSc …
vasculopathy, and fibrosis which affects the skin and internal organs. One key aspect of SSc …
Role of left ventricular dysfunction in systemic sclerosis-related pulmonary hypertension
JK Lui, M Cozzolino, M Winburn, MA Trojanowski… - Chest, 2024 - Elsevier
Background In systemic sclerosis (SSc), pulmonary hypertension remains a significant
cause of morbidity and mortality. Although conventionally classified as group 1 pulmonary …
cause of morbidity and mortality. Although conventionally classified as group 1 pulmonary …
枸橼酸西地那非治疗结缔组织病相关性肺动脉高压的疗效观察
李雪玲， 王璐瑶， 左正才， 王贵红 - 中华全科医学, 2023 - zhqkyx.net
目的探讨结缔组织病相关性肺动脉高压(CTD-PAH) 患者口服枸橼酸西地那非治疗前后血流动力
学参数及运动能力的变化, 以评价其临床疗效. 方法选择2022 年1 月1 日—2023 年3 月1 …
学参数及运动能力的变化, 以评价其临床疗效. 方法选择2022 年1 月1 日—2023 年3 月1 …
Efficacy of sildenafil citrate in treating pulmonary hypertension associated with connective tissue disease
LI Xueling, W Luyao, ZUO Zhengcai, W Guihong - 中华全科医学, 2023 - zhqkyx.net
Objective To investigate the changes of hemodynamic parameters and exercise ability in
patients with pulmonary hypertension associated with connective tissue disease (CTD-PAH) …
patients with pulmonary hypertension associated with connective tissue disease (CTD-PAH) …
Emphysema and interstitial lung disease in systemic sclerosis-related pulmonary hypertension
J Vakhshoorzadeh, JK Lui, RA Sangani… - Respiratory …, 2023 - resmedjournal.com
2. Results Baseline demographics are summarized in Table 1. There were 88 patients with
SSc-PH divided into 4 categories: 1) 26 (29.5%) with PH only; 2) 12 (13.6%) with …
SSc-PH divided into 4 categories: 1) 26 (29.5%) with PH only; 2) 12 (13.6%) with …